Fundraising Fox
ApiJect Holdings
Stamford, US · Founded 2022 · Delaware corporation · 5 known investors
Find your way into ApiJect Holdings
Sign up to see every warm intro you have to ApiJect Holdings
- Paths you didn't know you had: your email and LinkedIn already hold routes to the ApiJect Holdings team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
ApiJect develops a platform for producing prefilled injectable medicines and vaccines, aimed at making injectable drug delivery safer and more accessible. It serves manufacturers of sterile liquid products in the pharmaceutical and healthcare industry.
Founders & leadership
ApiJect Holdings was founded in 2022 by Jay Walker.
JW
Jay WalkerFounder · Executive ChairmanJay Walker founded Priceline and Synapse Group and holds a B.S. in Industrial Relations from Cornell. He serves as Chairman and CEO of ApiJect Systems Corp., focusing on platforms for producing prefilled injectable medicines and vaccines.
PS
Peter StoneNamed on SEC filing
HI
Hanjin InNamed on SEC filing
RB
Raphael BejaranoNamed on SEC filing
MK
Marc KoskaNamed on SEC filing
KS
Kevin SheridanNamed on SEC filing
Investors · 5
JefferiesreportedNew York
How we know: funding news · Not right? Tell us
Also in the syndicate · 4
Jefferies Financial GroupleadJefferies Financial Group Inc.Royalty PharmaleadRoyalty Pharma plc
Reported raises · per SEC filings
Form D private placements$111M disclosed across 1 round · 2022
▶$111MraisedMay 2022 · 4 investors · OtherRule 506(b)
▶$111MraisedMay 2022 · 4 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Peter StoneExecutive Officer
- Hanjin InDirector
- Raphael BejaranoDirector
- Jay WalkerDirector, Executive Officer
- Marc KoskaDirector
- Kevin SheridanDirector
- Offering amount
- $162.4M
- Amount sold
- $111M
- Proceeds to insiders
- $7.9M
- First sale
- Apr 2022
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 3
TempusTempus AI develops artificial intelligence-powered diagnostic tests that integrate genomic, clinical, and imaging data to guide personalized treatment decisions in oncology and other disease areas. The company operates a technology platform that connects healthcare institutions to aggregate and analyze multimodal patient data, serving physicians, pharmaceutical companies, and healthcare systems seeking to optimize therapy selection and drug development.
Boston ScientificBoston Scientific supports external researcher-initiated studies through its Investigator Sponsored Research program, which funds independent investigations addressing disease understanding and treatment gaps of interest to the medical community.
Paragon28Paragon 28 manufactures the PRECISION MIS Bunion System, a minimally invasive surgical instrument set for correcting bunion deformities through metatarsal osteotomy and fixation. The system is designed for orthopedic surgeons and hospitals performing bunion correction procedures.
Companies working in the same space as ApiJect Holdings.
Frequently asked questions
- What does ApiJect Holdings do?
- ApiJect develops a platform for producing prefilled injectable medicines and vaccines, aimed at making injectable drug delivery safer and more accessible. It serves manufacturers of sterile liquid products in the pharmaceutical and healthcare industry.
- Who founded ApiJect Holdings?
- ApiJect Holdings was founded by Jay Walker in 2022.
- Who are ApiJect Holdings's investors?
- ApiJect Holdings's investors include Jefferies.
- How much funding has ApiJect Holdings raised?
- ApiJect Holdings has disclosed $111M raised across 1 round.
- Where is ApiJect Holdings headquartered?
- ApiJect Holdings is headquartered in Stamford, US.